Multimarker strategy in acute coronary syndrome—pro‐multimarker

References

• The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21: 1502–13
   PubMed Web of Science ®Google Scholar
• Katus H. A., Remppis A., Neumann F. J., Scheffold T., Diederich K. W., Vinar G., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902–12
   PubMed Web of Science ®Google Scholar
• Falk E., Shah P. K., Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71
   PubMed Web of Science ®Google Scholar
• Ricciardi M. J., Wu E., Davidson C. J., Choi K. M., Klocke F. J., Bonow R. O., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase‐MB elevation. Circulation 2001; 103: 2780–3
   PubMed Web of Science ®Google Scholar
• Ottani F., Galvani M., Nicolini F. A., Ferrini D., Pozzati A., Di Pasquale G., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140: 917–27
   PubMed Web of Science ®Google Scholar
• Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L. Markers of myocardial damage and inflammation in relation to long‐term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139–47
   PubMed Web of Science ®Google Scholar
• Frey N., Dietz A., Kurowski V., Giannitsis E., Tolg R., Wiegand U., et al. Angiographic correlates of a positive troponin T test in patients with unstable angina. Crit Care Med 2001; 29: 1130–6
   Google Scholar
• Okamatsu K., Takano M., Sakai S., Ishibashi F., Uemura R., Takano T., et al. Elevated troponin T levels and lesion characteristics in non‐ST‐elevation acute coronary syndromes. Circulation 2004; 109: 465–70
   Google Scholar
• Lindahl B., Venge P., Weallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long‐term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997; 29: 43–8
   PubMed Web of Science ®Google Scholar
• Braunwald E., Antman E. M., Beasley J. W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non‐ST‐segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol 2000; 36: 970–1062
   PubMed Web of Science ®Google Scholar
• Hamm C. W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C. M., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623–9
   PubMed Web of Science ®Google Scholar
• Cannon C. P., Weintraub W. S., Demopoulos L. A., Vicari R., Frey M. J., Lakkis N., et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)‐Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879–87
   PubMed Web of Science ®Google Scholar
• Liuzzo G., Biasucci L. M., Gallimore J. R., et al. The prognostic value of C‐reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417–24
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Rifai N., Antman E. M., et al. C‐reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A Substudy. J Am Coll Cardiol 1998; 31: 1460–5
   PubMed Web of Science ®Google Scholar
• De Winter R. J., Bholasingh R., Lijmer J. G., Koster R. W., Gorgels J. P. M. C., Schouten Y., et al. Independent prognostic value of C‐reactive protein and troponin I in patients with unstable angina or non‐Q‐wave myocardial infarction. Cardiovasc Res 1999; 42: 240–5
   PubMed Web of Science ®Google Scholar
• Heeschen C., Hamm C. W., Bruemmer J., Simoons M. L., for the CAPTURE Investigators. Predictive value of C‐reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol 2000; 35: 1535–42
   PubMed Web of Science ®Google Scholar
• Goetze J. P., Christoffersen C., Perko M., Arendrup H., Rehfeld J. F., Kastrup J., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105–7
   PubMed Web of Science ®Google Scholar
• Galvani M., Ferrini D., Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 2004; 6: 327–33
   Google Scholar
• Morrow D. A., de Lemos J. A., Sabatine M. S., Murphy S. A., Demopoulos L. A., DiBattiste P. M., et al. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation MI: BNP and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–72
   PubMed Web of Science ®Google Scholar
• Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in acute coronary syndromes. Circulation 2002; 106: 2913–8
   PubMed Web of Science ®Google Scholar
• Morrow D. A., de Lemos J. A., Sabatine M. S., Murphy S. A., Demopoulos L. A., DiBattiste P. M., et al. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation myocardial infarction: B‐type natriuretic peptide and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–72
   PubMed Web of Science ®Google Scholar
• Mega J. L., Morrow D. A., De Lemos J. A., Sabatine M. S., Murphy S. A., Rifai N., et al. B‐type natriuretic peptide at presentation and prognosis in patients with ST‐segment elevation myocardial infarction: an ENTIRE‐TIMI‐23 substudy. J Am Coll Cardiol 2004; 44: 335–9
   PubMed Web of Science ®Google Scholar
• James S. K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., et al. N‐terminal pro‐brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003; 108: 275–81
   PubMed Web of Science ®Google Scholar
• Morrow D. A., de Lemos J. A., Sabatine M. S., et al. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation myocardial infarction: B‐type natriuretic eptide and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41: 1264–72
   PubMed Web of Science ®Google Scholar
• Jernberg T., Lindahl B., Siegbahn A., et al. N‐terminal pro brain natriuretic peptide in relation to inflammation, myocardial necrosis and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003; 42: 1909–16
   PubMed Web of Science ®Google Scholar
• Brennan M. L., Penn M. S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595–604
   PubMed Web of Science ®Google Scholar
• Heeschen C., Dimmeler S., Hamm C. W., van den Brand M. J., Boersma E., Zeiher A. M., et al. CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104–11
   PubMed Web of Science ®Google Scholar
• Bayes‐Genis A., Conover C. A., Overgaard M. T., Bailey K. R., Christiansen M., Holmes D. R., Jr., et al. Pregnancy‐associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022–9
   PubMed Web of Science ®Google Scholar
• Heeschen C., Dimmeler S., Fichtlscherer S., Hamm C. W., Berger J., Simoons M. L., et al. CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004; 291: 435–41
   PubMed Web of Science ®Google Scholar
• Antman E. M., Cohen M., Bernink P. J., McCabe C. H., Horacek T., Papuchis G., et al. The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–42
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Snapinn S. M., McCabe C. H., Theroux P., Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non‐ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM‐PLUS. Eur Heart J 2002; 23: 223–9
   PubMed Web of Science ®Google Scholar
• Sabatine M. S., Morrow D. A., de Lemos J. A., Gibson C. M., Murphy S. A., Rifai N., et al. Multimarker approach to risk stratification in non‐ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C‐reactive protein, and B‐type natriuretic peptide. Circulation 2002; 105: 1760–3
   PubMed Web of Science ®Google Scholar
• Baldus S., Heeschen C., Meinertz T., Zeiher A. M., Eiserich J. P., Munzel T., et al. CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440–5
   PubMed Web of Science ®Google Scholar
• Lund J., Qin Q. P., Ilva T., Pettersson K., Voipio‐Pulkki L. M., Porela P., et al. Circulating pregnancy‐associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003; 108: 1924–6
   PubMed Web of Science ®Google Scholar
• James S., Armstrong P., Califf R., Simoons M. L., Venge P., Wallentin L., et al. Troponin T levels and risk of 30‐day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO‐IV trial. Am J Med 2003; 115: 178–84
   PubMedGoogle Scholar